The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at ...

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

A novel daily toric lens for astigmatism offers satisfactory comfort and vision for patients previously dissatisfied with toric lenses.

Eye strain is more severe on screen than paper, suggesting that mode of presentation in near work influences symptoms.

Children older than 7 years have a higher risk of glaucoma upon undergoing cataract surgery and receiving secondary intraocular lenses.

SCREEN-ROP can effectively identify infants who require treatment for retinopathy of prematurity, a study shows.

Patients with glaucoma or dry eye disease are likely to have additional systemic conditions that makes self-administration of drops difficult.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

BoNT-A injections may temporarily impair ocular surface stability, affecting meibomian gland function and tear film stability.

Epi-on demonstrates a more favorable safety profile than epi-off corneal cross-linking in patients with corneal ectasia.

Compared with single-vision lens wear, 2 years of orthokeratology lens wear can slow axial elongation for at least 11 years ...

AI models can detect center-involved diabetic macular edema with visual impairment using color fundus photographs and OCT scans.